- Home
- FDMT vs UROY Comparison
FDMT vs UROY Comparison
Compare FDMT & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | UROY |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | Canada |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 404.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDMT | UROY |
|---|---|---|
| Price | $10.07 | $2.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $31.71 | N/A |
| AVG Volume (30 Days) | 868.4K | ★ 2.3M |
| Earning Date | 05-08-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | $279.20 |
| Revenue Next Year | $70.28 | N/A |
| P/E Ratio | ★ N/A | $1,584.46 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $4.27 | $2.42 |
| 52 Week High | $14.00 | $5.52 |
Technical Indicators
Market Signals| Indicator | FDMT | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 50.75 |
| Support Level | $9.71 | $2.60 |
| Resistance Level | $10.50 | $2.96 |
| Average True Range (ATR) | 0.79 | 0.16 |
| MACD | -0.30 | 0.06 |
| Stochastic Oscillator | 9.04 | 60.50 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.